Results 11 to 20 of about 2,314,750 (241)
Background and objective: Although the ultimate pathogenesis of polycystic ovary syndrome remains obscure, the distinctive feature is the failure of follicular maturation resulting in an ovulation and accumulation of preantral and small antral follicles ...
Jwan J. Namik +2 more
doaj +2 more sources
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study [PDF]
The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest.
Fortner, Renée T. +26 more
core +9 more sources
Objective: To assess the levels of anti-Mullerian hormone in women with type I diabetes mellitus during their reproductive age period. Background: Reproductive impairment in poorly controlled type one diabetes mellitus results from perturbations at ...
Masar Mahdi Al Khafaji +2 more
doaj +2 more sources
Anti-Mullerian hormone and cardiometabolic status: a systematic review
To summarise the relationship between Anti-mullerian hormone (AMH) levels and cardiometabolic status in different populations. PubMed, Scopus, and Embase were searched for retrieving observational studies published up to February 2022 investigating the relationship between AMH level and cardiometabolic status. Of 3,643 studies retrieved from databases,
Aida, Fallahzadeh +4 more
openaire +3 more sources
Comparison between the levels of anti mullerian hormone after treatment with clomid versus letrozole in polycystic women: an experimental study [PDF]
Objective: To compare the effect of two ovulation induction drugs on anti-Mullerian hormone level in polycystic women. Method: The experimental cohort study was done at the infertility outpatient clinics of Al-Yarmouk Teaching Hospital, Baghdad, Iraq,
Manal Madany Abdel Qader +2 more
doaj +2 more sources
Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in in vitro fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing.
Duru Shah, Padma Rekha Jirge
doaj +2 more sources
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception [PDF]
<p>Background - Chronological age and oocyte yield are independent determinants of live birth in assisted conception. Anti-Müllerian hormone (AMH) is strongly associated with oocyte yield after controlled ovarian stimulation.
Grisendi, V. +6 more
core +2 more sources
Aim This study aimed to evaluate the correlations among anti‐Müllerian hormone levels, body mass index and lipid profile in female nurses of reproductive age. Design This is a descriptive cross‐sectional study that used data from the Korea Nurses' Health
Sarah Lim +6 more
doaj +1 more source
Decreased Ovarian Reserve Predicts Inexplicability of Recurrent Miscarriage? A Retrospective Analysis. [PDF]
OBJECTIVE:To evaluate anti-Mullerian hormone, basal follicle stimulating hormone, luteinizing hormone, estradiol, and female age in women with recurrent miscarriage and to compare women with explained and idiopathic recurrent miscarriage.
Sophie Pils +4 more
doaj +1 more source
Anti-Müllerian Hormone and Metabolic-Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population-Based Study. [PDF]
In this population‐based study of 883 women, AMH declined less with age in women with PCOS than in healthy women. Higher AMH may protect older healthy women from T2DM but indicates elevated metabolic risk in younger women with PCOS, supporting its role as a life‐course biomarker for metabolic risk stratification.
Ramezani Tehrani F +5 more
europepmc +2 more sources

